Chargement des cours...
Prévisions
Aucune donnée d'analyste n'est disponible pour cette entreprise.
Discussions dans la communauté
Il n'y a pas encore de discussion sur cet actif.
Lancer une discussionActualités Accéder au fil d'actualités
SYNBIOTIC SE: subsidiary Hempro International applies for preliminary insolvency proceedings
Management of Hempro International has announced it will file an application with the Münster district court to open preliminary insolvency proceedings. The causes are a marked drop in demand and sales since March 2026 due to worsening economic conditions following geopolitical events. SYNBIOTIC SE is reconsidering the operational development of its subsidiaries as part of restructuring measures and will no longer continue financial support for Hempro; potential impacts on the balance sheet and results are being reviewed. » Plus sur finanzen.net
SynBiotic share plunges almost 20% after US cannabis reclassification
The SynBiotic share lost 14.4% in Xetra trading and fell a further almost 20% in after-hours trading. The trigger was the official initiation of a US reclassification of cannabis intended to make medical use easier but not to provide nationwide legalization for recreational purposes. Ahead of this, the stock had already benefited from speculation about a loosening of US rules. » Plus sur finanzen.net
Synbiotic shares more than double since Friday after anchor investor steps in
Synbiotic shares rose by more than 100% since Friday and continued on Wednesday with a gain of over 12% to 3.55 euros; intraday they reached up to 3.78 euros. Earlier in the week the papers had already climbed by as much as 42% after they had marked a record low near 1.50 euros last week. Analyst Harald Hof cited several positive triggers: two smaller capital increases, the insolvency of a non-core subsidiary, sector tailwinds and the entry of the hemp equity fund Cansoul as a new anchor investor in a cash capital increase. » Plus sur de.investing.com
SYNBIOTIC SE decides on capital increase of up to 200,000 new shares
SYNBIOTIC SE is using authorized capital to increase share capital by up to EUR 200,000 through the issuance of up to 200,000 new registered shares at a placement price of EUR 1.70 per share, with statutory subscription rights excluded. The new shares will be entitled to profits from 1 January 2024; Small & Mid Cap Investmentbank AG has been appointed to handle the placement. The net proceeds from the issuance are intended to support the company's growth. » Plus sur finanzen.net
SYNBIOTIC: subsidiary Bushdoctor files for insolvency proceedings
Bushdoctor GmbH has applied to the Landesgericht Wiener Neustadt to open insolvency proceedings. As part of the restructuring, SYNBIOTIC suspended financial support for the subsidiary, which led to the filing. The announcement confirms that the operational development of the subsidiaries is being reviewed as part of the group restructuring. » Plus sur finanzen.net
Dividendes historiques Dividendes
Tous les indicateurs de dividendes Tous les indicateursDonnées financières de l'entreprise
| (EUR) | 2024 | YoY |
|---|---|---|
| Chiffre d'affaires | 14,31 M | 270,47 % |
| Bénéfice brut | 4,86 M | 222,69 % |
| Bénéfice net | -9,72 M | 8,60 % |
| EBITDA | -2,03 M | 71,55 % |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 991,04 k € |
Nombre d'actions | 7,99 M |
Plus haut/bas sur 52 semaines | 3,85 € - 0,10 € |
| Dividendes | Non |
Bêta | 0,68 |
Ratio P/E | -0,07 |
Ratio PEG | 0,00 |
Ratio P/B | 0,03 |
Ratio P/S | 0,07 |
Profil de l'entreprise
SynBiotic SE développe des médicaments et des produits de bien-être en vente libre à base de cannabinoïdes. Elle se concentre sur la production synthétique de cannabinoïdes, le développement de médicaments, les compléments alimentaires et les produits cosmétiques. La société était auparavant connue sous le nom de Ledgertech SE et a changé de nom pour devenir Ledgertech SE. SynBiotic SE est basée à Munich, en Allemagne.
| Nom | SynBiotic |
| PDG | Daniel Kruse |
| Siège social | Düsseldorf,
nw Allemagne |
| Site web | |
| Secteur | Santé |
| Industrie | Biotechnologie |
| Introduction en bourse | 07/01/2021 |
| Employés | 79 |
Deep Dive
Symboles boursiers
| Bourse | Symbole |
|---|---|
XETRA | SBX.DE |
Frankfurt | SBX.F |
Düsseldorf | SBX.DU |
Hamburg | SBX.HM |
München | SBX.MU |
SIX | SBX.SW |